Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4773694 | 0.83 | ALDH1A1 (0.37) | TSHRUSP2LMNACYP3A4MAPT | |
| SCHEMBL1973010 | 0.82 | GRIK1 (0.40) | TSHRUSP2LMNACYP3A4MAPT | |
| SCHEMBL7483838 | 0.82 | TSHR (0.31) | TSHR | |
| SCHEMBL3607061 | 0.82 | ALDH1A1 (0.39) | TSHRLMNASMN1; SMN2 | |
| SCHEMBL4766772 | 0.82 | TSHR (0.42) | TSHRCYP3A4MAPT | |
| SCHEMBL30979219 | 0.80 | GRIK1 (0.39) | TSHRUSP2LMNACYP3A4MAPT | |
| SCHEMBL30979220 | 0.80 | GRIK1 (0.39) | TSHRUSP2LMNACYP3A4MAPT | |
| Acetic Acid SCHEMBL28822001 | 0.79 | MMP8 (0.37) | TSHRLMNASMN1; SMN2 | |
| SCHEMBL8183510 | 0.79 | SMN1; SMN2 (0.32) | TSHRCYP3A4MAPTSMN1; SMN2 | |
| SCHEMBL31585 | 0.78 | GRIK1 (0.42) | LMNAMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070191606-A1 | 2,2-Bis(4-hydroxyphenyl)-alkyl onium salt and process for the preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-08-16 | — | — | US | claimed |
| EP-1818336-A1 | 2,2-bis-(4-hydroxyphenyl)-alkyl onium salt and a process for the preparation thereof | Council of Scientific and Industrial Research (IN) | 2007-08-15 | — | — | EP | claimed |
| US-20070191606-A1 | 2,2-Bis(4-hydroxyphenyl)-alkyl onium salt and process for the preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-08-16 | — | — | US | disclosed |
| EP-1818336-A1 | 2,2-bis-(4-hydroxyphenyl)-alkyl onium salt and a process for the preparation thereof | Council of Scientific and Industrial Research (IN) | 2007-08-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191606-A1 | 2,2-Bis(4-hydroxyphenyl)-alkyl onium salt and process for the preparation thereof | HACL2, HAO2, HPD | TSHR 4769/4885USP2 775/4885LMNA 2170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.